crizotinib
Megjelenés
| Clinical data | |
|---|---|
| Trade names | Xalkori, others |
| Other names | PF-02341066 1066 |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a612018 |
| License data |
|
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | 43% |
| Protein binding | 91% |
| Metabolism | Liver (CYP3A4/CYP3A5-mediated) |
| Elimination half-life | 42 hours |
| Excretion | Faeces (63%), urine (22%) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| PDB ligand | |
| Chemical and physical data | |
| Formula | C21H22Cl2FN5O |
| Molar mass | 450.339403163 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Főnév
crizotinib (tsz. crizotinibs)
- crizotinib - Szótár.net (en-hu)
- crizotinib - Sztaki (en-hu)
- crizotinib - Merriam–Webster
- crizotinib - Cambridge
- crizotinib - WordNet
- crizotinib - Яндекс (en-ru)
- crizotinib - Google (en-hu)
- crizotinib - Wikidata
- crizotinib - Wikipédia (angol)